FERNANDO ANTONIO
RODRÍGUEZ DE FONSECA
Catedrático de universidad
![Foto de Emilio](/img/nophoto.png)
Emilio
Fernández-Espejo
Publicaciones en las que colabora con Emilio Fernández-Espejo (15)
2022
-
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease
Clinical Parkinsonism and Related Disorders, Vol. 7
2021
-
ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease
Parkinsonism and Related Disorders, Vol. 88, pp. 3-9
-
Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose
Brain Research, Vol. 1761
2018
-
Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia
Cannabis and Cannabinoid Research, Vol. 3, Núm. 1, pp. 171-178
2014
-
The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism
International Journal of Neuropsychopharmacology, Vol. 17, Núm. 3, pp. 455-468
2013
-
Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism
Addiction Biology, Vol. 18, Núm. 1, pp. 78-87
2010
-
Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice
Synapse, Vol. 64, Núm. 5, pp. 379-389
2009
-
Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons
Neuropharmacology, Vol. 56, Núm. 3, pp. 653-664
-
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Psychopharmacology, Vol. 206, Núm. 4, pp. 531-549
-
The absence of a functional peroxisome proliferator-activated receptor-alpha gene in mice enhances motor sensitizing effects of morphine, but not cocaine
Neuroscience, Vol. 164, Núm. 2, pp. 667-675
2008
-
Expression and function of CB1 receptor in the rat striatum: Localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors
Neuropsychopharmacology, Vol. 33, Núm. 7, pp. 1667-1679
2007
-
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies
European Journal of Pharmacology, Vol. 559, Núm. 2-3, pp. 180-183
2005
-
Acute Δ9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion
Pharmacology Biochemistry and Behavior, Vol. 81, Núm. 1, pp. 71-77
-
Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism
Neurobiology of Disease, Vol. 18, Núm. 3, pp. 591-601
2004
-
Experimental Parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: A modulator of endocannabinoid function
Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 1134-1142